Full-Time

Test Cloud Account Executive

Healthcare & Life Sciences

Updated on 9/3/2026

UiPath

UiPath

5,001-10,000 employees

Automates business processes with RPA software

No salary listed

Remote in USA + 3 more

More locations: Texas, USA | Florida, USA | Georgia, USA

Remote

Travel of approximately 25% is required.

Category
Sales & Account Management (1)
Required Skills
ERP
Software Testing
DevOps
HIPAA

Get referred to UiPath

See people who can refer or advise you

Requirements
  • At least 8 years of enterprise software or solution/value selling experience focused on software testing, quality engineering, or DevOps/CI-CD tooling.
  • At least 5 years of experience managing and growing Enterprise Healthcare and Life Sciences accounts within Providers, Payers, BioPharma, or Medical Device organizations.
  • Experience selling transformational technologies including test automation, artificial intelligence, software as a service, cloud, or digital quality and compliance solutions.
  • A proven track record of exceeding quota and driving large, complex enterprise deals.
  • Ability to communicate testing and quality automation capabilities, return on investment, compliance and validation impact, and implementation strategy to executive, quality, and technical audiences.
  • Strong consultative selling skills and the ability to translate complex technology concepts into clear business and compliance outcomes.
  • Executive presence and experience engaging stakeholders across Quality, Information Technology, Compliance, and Operations functions, including the C-suite.
  • Strong account planning and opportunity management skills using a research-driven, data-oriented approach.
  • Demonstrated ability to collaborate cross-functionally and influence internal and external stakeholders.
  • Ability to travel approximately 25%.
  • Authorization to work in the United States.
Responsibilities
  • Own and grow a portfolio of Enterprise Healthcare and Life Sciences accounts, driving expansion of Test Cloud adoption across business units and functions.
  • Develop and execute territory and account strategies aligned to customer quality, validation, and digital transformation priorities alongside UiPath growth objectives.
  • Build trusted relationships with Quality, Validation, Information Technology, Quality Assurance, Digital Transformation leaders, AI Centers of Excellence, and Shared Services organizations.
  • Position UiPath Test Cloud using a consultative, value-based sales approach focused on faster release cycles, reduced defect escape rates, lower validation costs, and stronger audit readiness.
  • Lead complex enterprise sales cycles involving multiple stakeholders, cross-functional teams, and partner ecosystems.
  • Identify opportunities to expand automated testing adoption across EHR/EMR systems, clinical trial and safety systems, manufacturing and quality management systems, claims and payer platforms, ERP, and other regulated business-critical applications.
  • Collaborate with Customer Success, Solutions Engineering, Marketing, and Partner teams to ensure successful customer outcomes and long-term account growth.
  • Partner with Global Systems Integrators and strategic testing and quality partners to cultivate new opportunities and accelerate customer value realization.
  • Maintain strong knowledge of Healthcare and Life Sciences industry trends, the competitive software testing landscape, regulatory considerations, and emerging AI-driven testing initiatives.
Desired Qualifications
  • Familiarity with the regulatory and validation landscape unique to Healthcare and Life Sciences, including GxP, computer system validation, 21 CFR Part 11, and HIPAA.

UiPath creates software that helps businesses automate repetitive tasks using robotic process automation (RPA). Its products design AI-driven workflows, run bots, and manage automation in the cloud or on-premises. Customers license the software or subscribe to cloud services, receive professional support, and can access a marketplace of third-party integrations to extend the platform. The system works by letting users build and deploy automation workflows that coordinate across different applications, with a central orchestrator to schedule and monitor bots in real time. What sets UiPath apart is its large and growing ecosystem, extensive integrations, and scalable cloud-based orchestration that supports enterprise deployments across many industries. The goal is to reduce operating costs and raise productivity by expanding automated processes throughout organizations.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

New York City, New York

Founded

2005

Get referred to UiPath

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 3, 2026 results showed 13% revenue growth and 12% ARR growth.
  • 18 of 20 top deals included AI features, signaling stronger product pull.
  • stc Bahrain's September 2026 reseller deal expands UiPath's Middle East channel.

What critics are saying

  • BofA's September 2026 Underperform call says AI growth remains unproven.
  • The March 2026 Delaware derivative suit targets executives over slowing growth and insider sales.
  • If agentic orchestration stays a feature, UiPath becomes a shrinking point-solution vendor.

What makes UiPath unique

  • Maestro unifies bots, AI agents, systems, and humans under one governance layer.
  • UiPath's 10,350-customer base gives Maestro immediate upsell distribution.
  • Model-agnostic orchestration lets enterprises swap OpenAI, Anthropic, and Microsoft models.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Sep 9th, 2026
UiPath reports 12% ARR growth and 22% operating margin in Q2 2027 earnings

UiPath reported second quarter fiscal 2027 results showing annual recurring revenue growth of 12%. The automation software company achieved a non-GAAP operating margin of 22% and posted its fourth consecutive quarter of GAAP profitability. Founder and CEO Daniel Dines said UiPath has been transforming over the past two years to prepare for its next growth phase. The company has evolved its platform to include business orchestration, agentic capabilities, and software testing whilst improving go-to-market execution and operating discipline. Dines noted that customers increasingly view UiPath as a critical partner in their AI transformation. They're turning to the company not just for automating individual tasks but for orchestrating complex, long-running business processes with multiple exceptions. The company held its earnings call on 3 September 2026, with executives including COO Ashim Gupta and CFO Hitesh Ramani joining Dines to discuss the results.

Associated Press
Sep 8th, 2026
Synthesized launches UiPath integration to automate test data provisioning for continuous testing

Synthesized has launched an integration with UiPath Test Cloud to automate test data provisioning within testing workflows. The AI-native test data automation platform enables teams to invoke configured data workflows as part of their UiPath testing process, addressing delays caused by unavailable, consumed, or non-compliant test data. The integration allows test data preparation to become a native step inside UiPath Test Cloud rather than a separate manual process. Synthesized generates, transforms, or provisions required data whilst applying configured privacy treatments and relationship rules for selected scenarios. The integration supports end-to-end workflows from defining requirements through to test execution and workflow reuse. It is now available and was showcased at UiPath FUSION 2026 in Las Vegas, where Synthesized was the only test data vendor sponsoring the event.

Yahoo Finance
Sep 8th, 2026
UiPath wins higher price targets from BofA and Truist, but analysts still await AI-driven growth proof

UiPath received higher price targets from several Wall Street analysts following its second-quarter results, though enthusiasm remains muted amid questions about AI's impact on growth. Bank of America raised its price target to $15 from $13 but maintained an Underperform rating, stating the AI opportunity remains unproven for boosting annual recurring revenue growth. Truist lifted its target to $17 from $12 whilst keeping a Hold rating. TD Cowen increased its target to $16 from $13, citing steady execution and growing AI adoption. DA Davidson also raised its target to $16 from $12, maintaining a Neutral rating. UiPath's second-quarter revenue rose 13% to $410.26 million, exceeding analyst estimates of $397.8 million. Adjusted earnings matched expectations at $0.15 per share.

Yahoo Finance
Sep 5th, 2026
UiPath Q2 2027: AI drives 18 of top 20 deals as coding agents cut implementation effort 60%

UiPath reported its fourth consecutive quarter of GAAP profitability in Q2 2027, driven by a 42% year-over-year reduction in stock-based compensation expense. The automation software company is shifting its strategy from individual task automation to complex business process orchestration, combining deterministic automation with AI capabilities. Management noted that 18 of the top 20 deals this quarter included AI features. The company is positioning itself as model-agnostic, allowing enterprises to integrate various AI models whilst maintaining governance within its platform. UiPath announced leadership changes, with Ashim Gupta moving to COO and Hitesh Ramani to CFO, aimed at driving operational discipline across its global sales organisation. The firm is also shifting towards vertical, outcome-oriented solutions in sectors like healthcare and finance. The company expects FX headwinds of $18 million in the second half and is exploring transaction-based and outcome-based pricing models.

Insider Monkey
Sep 4th, 2026
UiPath (PATH) grew ARR 12% as net retention rate reached 109%. Can agentic automation reaccelerate expansion?

UiPath (PATH) grew ARR 12% as net retention rate reached 109%. Can agentic automation reaccelerate expansion? Published September 4, 2026 at 7:33 pm EDT UiPath, Inc. (NYSE:PATH) reported fiscal second-quarter revenue of $410.3 million, up 13% year over year, while annualized renewal run-rate, or ARR, rose 12% to $1.938 billion. UiPath, Inc. defines ARR as annualized invoiced amounts per solution SKU from subscription licenses and maintenance and support obligations, assuming no increases or reductions in customer subscriptions. The company-defined operating metric excludes perpetual licenses and professional services. It also does not reflect nonrecurring partner rebates once sufficient history establishes their nonrecurring nature, nonrecurring incentives such as promotional discounts, or actual or anticipated invoiced reductions from nonrenewals or cancellations, other than certain reserves. Net new ARR, the sequential net addition to ARR, increased to $37 million from $31 million one year earlier. The dollar-based net retention rate rose to 109% from 108%. This rate compares ARR from the same customer cohort across 12 months, including expansion and subtracting contraction and attrition while excluding new customers. Profitability improved more sharply. UiPath, Inc. generated $31.6 million of GAAP operating income, versus a $20.2 million loss one year earlier. Company-defined non-GAAP operating income increased to $89.0 million from $62.3 million. The measure excludes stock-based compensation, acquired-intangible amortization, payroll taxes related to employee equity transactions, restructuring costs, charitable stock donations, and contingent-consideration fair-value changes. Bull case. UiPath, Inc. has an installed enterprise automation base that provides a natural distribution channel for Maestro and other agentic capabilities. Maestro can serve as a control layer connecting AI agents, software robots, systems, and employees without requiring customers to replace existing robotic process automation. UiPath, Inc. introduced Maestro Case for dynamic processes involving exceptions and approvals and Maestro Flow for designing and governing end-to-end processes. These products could increase spending if customers move agentic projects from pilots into production. The earnings improvement provides room to fund the transition. GAAP operating margin reached approximately 8%, while company-defined non-GAAP operating margin was approximately 22%. UiPath, Inc. also held $1.405 billion of cash, cash equivalents, and marketable securities at quarter-end. Bear case. A 109% dollar-based net retention rate represents 9% net cohort expansion after contraction and attrition. A nine-percentage-point decline would eliminate that expansion. Net new ARR of $37 million also remains modest relative to the $1.938 billion installed base despite improving from the prior-year quarter. UiPath, Inc. did not disclose agentic-specific revenue, ARR, or consumption, leaving it unclear whether Maestro adoption is generating incremental spending or mainly supporting renewals. Competition is widening as major software platforms and specialized vendors add agents, orchestration, and embedded automation. Fiscal-year ARR guidance of $2.065 billion to $2.070 billion implies growth of approximately 11.4% to 11.7%. That supports continued expansion, but not yet a sharp reacceleration. Finance execution is another variable. Ashim Gupta will focus exclusively on the chief operating officer role, while Hitesh Ramani was promoted from deputy chief financial officer and chief accounting officer to chief financial officer. The internal promotion supports continuity, although forecasting, capital allocation, and financial controls still require a smooth handoff. Hedge fund sentiment. The filings available so far reflect positions held before UiPath, Inc. reported its fiscal second-quarter results and reset its finance leadership. Insider Monkey's database showed 48 hedge funds holding UiPath, Inc. at the end of 2Q2026, up from 40 funds three months earlier. Conclusion. UiPath, Inc. has achieved meaningful operating leverage, but customer expansion remains measured. The agentic thesis becomes stronger if net new ARR and the dollar-based net retention rate accelerate alongside disclosed adoption or consumption metrics. Until then, UiPath, Inc. is operating more efficiently while the case for agentic-driven growth is still being established.